Form D · Other Health Care

Attwill Vascular Technologies LP

Lodi, WI · CIK 0001834128

Offering snapshot reported Mar 7, 2022 · SEC filing

Reported sold
$1.71M
Offering amount: $2M
Investors reported
26
Form D · investor count
Minimum accepted
$1K
Reported outside-investor minimum
First sale
Dec 2, 2021
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$853K$1.71MDec 14, 2021: $985,000.00Dec 14, 2021Feb 3, 2022: $1,655,000.00Feb 3, 2022Mar 7, 2022: $1,705,000.00Mar 7, 2022

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,655,000 → $1,705,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 7, 2022Amendment$1,705,000$50,000vs Feb 3, 202226SEC filing
Feb 3, 2022Amendment$1,655,000$670,000vs Dec 14, 202126SEC filing
Dec 14, 2021Initial$985,000No comparison15SEC filing
Mar 11, 2021Initial$1,806,113No comparison25SEC filing
Dec 3, 2020Initial$1,910,250No comparison14SEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06b, 4a5
Duration over one year
No
Business combination
No
Sales commissions
$32.8K
Finders' fees
$0
Form D file number
021-424919
$2,000,000 of convertible notes, warrants to purchase up to $331,000 of securities, warrants to purchase up to $11,935 of securities (issuable as sales compensation), and securities issuable upon conversion or exercise of such offered securities.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Leede Jones Gable Inc.NoneLeede Jones Gable Inc.
ECHELON CAPITAL MARKETSNoneECHELON CAPITAL MARKETS

Source: Form D, filed Mar 7, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Richard Abraham Director
Robert Geoffery Browne Director
Attilio Di Fiore Director, Executive, Promoter
Ricardo Ferreira Director
William Jackson Director, Executive, Promoter
John Kennedy Director
John Schram Director
Tim Michael Shortly Director
John Timmothy Shortly Director
Attwill Vascular Technologies Inc. Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
925 Development Drive
Lodi, WI, 53555